Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/04/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/04/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 08/01/22 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
2 | |
| 07/25/22 | 8-K/A | Current report filing |
|
   |
3 |
| 07/25/22 | 8-K | Current report filing |
|
|
7 |
| 07/22/22 | DEF 14A | Definitive proxy statements |
|
19 | |
| 07/21/22 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/19/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 07/19/22 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 07/19/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
